BIO5 member Floyd "Ski" Chilton is part of a research team investigating how ancestry and genetics shape the body's response to omega-3 fatty acids with a $3.9 million grant from the National Institutes of Health.

BIO5 member Christopher Glembotski at University of Arizona College of Medicine-Phoenix is studying the molecular basis of heart disease to develop new treatments. His work, funded by a $2.8M NIH grant, could revolutionize heart disease care globally.

Hannah Pizzato, a researcher at the U of A Health Sciences Center for Advanced Molecular and Immunological Therapies, works in BIO5 member Deepta Bhattacharya’s lab to develop a stem cell-based therapy for Type 1 diabetes.